Please set your featured image
OGT helps reveal the role of NGS in stratified cancer medicine
Oxford Gene Technology (OGT), The Molecular Genetics Company, has teamed up with clinical research experts in a new article available online, discussing the role of next generation sequencing (NGS) in cancer medicine. The article, entitled “The role of NGS in stratified cancer medicine”, presents a valuable resource to better understand the present and the future of NGS in stratified cancer medicine, detailing the most relevant aspects of this revolutionary technology.
Oxford Gene Technology (OGT) provides world-class genetics research solutions to leading clinical and academic research institutions from their Oxfordshire base at Begbroke Science Park.